| # | Drug | Count |
|---|---|---|
| 0 | CARBIDOPA AND LEVODOPA | 27 |
| 1 | ASFOTASE ALFA | 20 |
| 2 | LEVETIRACETAM | 17 |
| 3 | CLOPIDOGREL | 15 |
| 4 | DEXAMETHASONE | 15 |
| 5 | DEXAMETHASONE 1.5 MG | 15 |
| 6 | FOLIC ACID | 15 |
| 7 | CLOPIDOGREL BISULFATE | 14 |
| 8 | PANTOPRAZOLE | 14 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASFOTASE ALFA | 20 | 0.0019 |
| 1 | HYALURONATE SODIUM | 2 | 0.0013 |
| 2 | CARBIDOPA LEVODOPA | 3 | 0.0008 |
| 3 | FOSCARBIDOPA/FOSLEVODOPA | 7 | 0.0008 |
| 4 | PHENYTOIN | 13 | 0.0006 |
| 5 | CARBIDOPA AND LEVODOPA | 27 | 0.0006 |
| 6 | TRIAMTERENE | 4 | 0.0005 |
| 7 | PERAMPANEL | 4 | 0.0005 |
| 8 | PHENTERMINE HYDROCHLORIDE | 3 | 0.0005 |
| 9 | AMANTADINE | 6 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatic Amino Acid [EPC] | 31 |
| 1 | Benzodiazepine [EPC] | 27 |
| 2 | Corticosteroid [EPC] | 24 |
| 3 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 23 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 20 |
| 6 | Vitamin B12 [EPC] | 18 |
| 7 | Vitamin C [EPC] | 18 |
| 8 | Vitamin D [EPC] | 18 |
| 9 | Proton Pump Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 20 | 0.0019 |
| 1 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 23 | 0.0008 |
| 2 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 5 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 6 | Aromatic Amino Acid [EPC] | 31 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 9 | Influenza A M2 Protein Inhibitor [EPC] | 6 | 0.0004 |